نتائج البحث

1

دورية أكاديمية

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

المؤلفون: Pellegrino, B, Cavanna, L, Boggiani, D, Zamagni, C, Frassoldati, A, Schirone, A, Caldara, A, Rocca, A, Gori, S, Piacentini, F, Berardi, R, Brandes, A A, Foglietta, J, Villa, F, Todeschini, R, Tognetto, M, Naldi, N, Bortesi, B, Montemurro, F, Ardizzoni, A, Boni, L, Musolino, A

المساهمون: Pellegrino, B, Cavanna, L, Boggiani, D, Zamagni, C, Frassoldati, A, Schirone, A, Caldara, A, Rocca, A, Gori, S, Piacentini, F, Berardi, R, Brandes, A A, Foglietta, J, Villa, F, Todeschini, R, Tognetto, M, Naldi, N, Bortesi, B, Montemurro, F, Ardizzoni, A, Boni, L, Musolino, A

مصطلحات موضوعية: TNBC, breast cancer, eribulin, gemcitabine, metastatic, pharmacogenetics

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000631402900017; volume:6; issue:1; firstpage:"-"; lastpage:"-"; numberofpages:8; journal:ESMO OPEN; https://hdl.handle.net/11368/3040098Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85100641127; https://www.sciencedirect.com/science/article/pii/S2059702920328842Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808100Test/

الإتاحة: https://doi.org/10.1016/j.esmoop.2020.100019Test
https://hdl.handle.net/11368/3040098Test
https://www.sciencedirect.com/science/article/pii/S2059702920328842Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808100Test/

View record in BASE

2

مؤتمر

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

المؤلفون: Musolino A, Cavanna L, Boggiani D, Zamagni C, Frassoldati A, Caldara A, Rocca A, Gori S, Piacentini F, Berardi R, Brandes AA, Foglietta J, Villa F, Pellegrino B, Todeschini R, Tognetto M, Naldi N, Bortesi B, Boni L, Montemurro F, Ardizzoni A

المساهمون: Musolino, A, Cavanna, L, Boggiani, D, Zamagni, C, Frassoldati, A, Caldara, A, Rocca, A, Gori, S, Piacentini, F, Berardi, R, Brandes, Aa, Foglietta, J, Villa, F, Pellegrino, B, Todeschini, R, Tognetto, M, Naldi, N, Bortesi, B, Boni, L, Montemurro, F, Ardizzoni, A

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000478677000278; ispartofbook:Proceedings; SABCS 2018; volume:79; issue:4; journal:CANCER RESEARCH; http://hdl.handle.net/11380/1169299Test

الإتاحة: https://doi.org/10.1158/1538-7445.SABCS18-P1-14-05Test
http://hdl.handle.net/11380/1169299Test

View record in BASE

3

دورية أكاديمية

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

المؤلفون: Parsons, M. T., Tudini, E., Li, H., Hahnen, E., Wappenschmidt, B., Feliubadaló, L., Aalfs, C. M., Agata, S., Aittomäki, K., Alducci, E., Alonso-Cerezo, M. C., Arnold, N., Auber, B., Austin, R., Azzollini, J., Balmaña, J., Barbieri, E., Bartram, C. R., Blanco Pérez, Ana, Blümcke, B., Bonache, S., Bonanni, B., Borg, Å, Bortesi, B., Brunet, J., Bruzzone, C., Bucksch, K., Cagnoli, G., Caldés, T., Caliebe, A., Caligo, M. A., Calvello, M., Capone, G. L., Caputo, S. M., Carnevali, I., Carrasco, E., Caux-Moncoutier, V., Cavalli, P., Cini, G., Clarke, E. M., Concolino, P., Cops, E. J., Cortesi, L., Couch, F. J., Darder, E., de la Hoya, M., Dean, M., Debatin, I., Del Valle, J., Delnatte, C., Derive, N., Diez, O., Ditsch, N., Domchek, S. M., Dutrannoy, V., Eccles, D. M., Ehrencrona, H., Enders, U., Evans, D. G., Farra, C., Faust, U., Felbor, U., Feroce, I., Fine, M., Foulkes, W. D., Galvao, H. C. R., Gambino, G., Gehrig, A., Gensini, F., Gerdes, A. M., Germani, A., Giesecke, J., Gismondi, V., Gómez, C., Gómez Garcia, E. B., González, S., Grau, E., Grill, S., Gross, E., Guerrieri-Gonzaga, A., Guillaud-Bataille, M., Gutiérrez-Enríquez, S., Haaf, T., Hackmann, K., Hansen, T. V. O., Harris, M., Hauke, J., Heinrich, T., Hellebrand, H., Herold, K. N., Honisch, E., Horvath, J., Houdayer, C., Hübbel, V., Iglesias, S., Izquierdo, A., James, P. A., Janssen, L. A. M., Jeschke, U., Kaulfuß, S., Keupp, K., Kiechle, M., Kölbl, A., Krieger, S., Kruse, T. A., Kvist, A., Lalloo, F., Larsen, M., Lattimore, V. L., Lautrup, C., Ledig, S., Leinert, E., Lewis, A. L., Lim, J., Loeffler, M., López-Fernández, A., Lucci-Cordisco, E., Maass, N., Manoukian, S., Marabelli, M., Matricardi, L., Meindl, A., Michelli, R. D., Moghadasi, S., Moles-Fernández, A., Montagna, M., Montalban, G., Monteiro, A. N., Montes, E., Mori, L., Moserle, L., Müller, C. R., Mundhenke, C., Naldi, N., Nathanson, K. L., Navarro, M., Nevanlinna, H., Nichols, C. B., Niederacher, D., Nielsen, H. R., Ong, K. R., Pachter, N., Palmero, E. I., Papi, L., Pedersen, I. S., Peissel, B., Perez-Segura, P., Pfeifer, K., Pineda, M., Pohl-Rescigno, E., Poplawski, N. K., Porfirio, B., Quante, A. S., Ramser, J., Reis, R. M., Revillion, F., Rhiem, K., Riboli, B., Ritter, J., Rivera, D., Rofes, P., Rump, A., Salinas, M., Sánchez de Abajo, A. M., Schmidt, G., Schoenwiese, U., Seggewiß, J., Solanes, A., Steinemann, D., Stiller, M., Stoppa-Lyonnet, D., Sullivan, K. J., Susman, R., Sutter, C., Tavtigian, S. V., Teo, S. H., Teulé, A., Thomassen, M., Tibiletti, M. G., Tischkowitz, M., Tognazzo, S., Toland, A. E., Tornero, E., Törngren, T., Torres-Esquius, S., Toss, A., Trainer, A. H., Tucker, K. M., van Asperen, C. J., van Mackelenbergh, M. T., Varesco, L., Vargas-Parra, G., Varon, R., Vega, A., Velasco, Á, Vesper, A. S., Viel, A., Vreeswijk, M. P. G., Wagner, S. A., Waha, A., Walker, L. C., Walters, R. J., Wang-Gohrke, S., Weber, B. H. F., Weichert, W., Wieland, K., Wiesmüller, L., Witzel, I., Wöckel, A., Woodward, E. R., Zachariae, S., Zampiga, V., Zeder-Göß, C., Investigators, K., Lázaro, C., De Nicolo, A., Radice, P., Engel, C., Schmutzler, R. K., Goldgar, D. E., Spurdle, A. B.

العلاقة: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772163/pdf/HUMU-40-1557.pdfTest; https://www.ncbi.nlm.nih.gov/pubmed/31131967Test; http://hdl.handle.net/20.500.11940/15792Test; 31799

الإتاحة: https://doi.org/20.500.11940/15792Test
https://doi.org/10.1002/humu.23818Test
https://hdl.handle.net/20.500.11940/15792Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772163/pdf/HUMU-40-1557.pdfTest
https://www.ncbi.nlm.nih.gov/pubmed/31131967Test

View record in BASE

4

كتاب

Introduction

المؤلفون: Rosselli A., Naldi N., Sanfilippo E.

المساهمون: Rosselli, A., Naldi, N., Sanfilippo, E., Rosselli, A., Naldi, N., Sanfilippo, E.

العلاقة: info:eu-repo/semantics/altIdentifier/isbn/978-1-138-08981-5; ispartofbook:Money, Finance and Crises: The long-term Impact of economic ideas; firstpage:1; lastpage:8; numberofpages:8; alleditors:Rosselli, A., Naldi, N., Sanfilippo, E.; http://hdl.handle.net/11580/70145Test

الإتاحة: http://hdl.handle.net/11580/70145Test

View record in BASE

5

دورية أكاديمية

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

المؤلفون: Pellegrino, B, Cavanna, L, Boggiani, D, Zamagni, C, Frassoldati, A, Schirone, A, Caldara, A, Rocca, A, Gori, S, Piacentini, F, Berardi, R, Brandes, A A, Foglietta, J, Villa, F, Todeschini, R, Tognetto, M, Naldi, N, Bortesi, B, Montemurro, F, Ardizzoni, A, Boni, L, Musolino, A

المساهمون: Pellegrino, B, Cavanna, L, Boggiani, D, Zamagni, C, Frassoldati, A, Schirone, A, Caldara, A, Rocca, A, Gori, S, Piacentini, F, Berardi, R, Brandes, A A, Foglietta, J, Villa, F, Todeschini, R, Tognetto, M, Naldi, N, Bortesi, B, Montemurro, F, Ardizzoni, A, Boni, L, Musolino, A

مصطلحات موضوعية: TNBC, breast cancer, eribulin, gemcitabine, metastatic, pharmacogenetics

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000631402900017; volume:6; issue:1; firstpage:100019; journal:ESMO OPEN; http://hdl.handle.net/11381/2886066Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85100641127

الإتاحة: https://doi.org/10.1016/j.esmoop.2020.100019Test
http://hdl.handle.net/11381/2886066Test

View record in BASE

6

دورية أكاديمية

Cambridge as a place in economics

المؤلفون: Marcuzzo, M, Naldi, N, Sanfilippo, E., ROSSELLI, ANNALISA

المساهمون: Marcuzzo, M, Naldi, N, Rosselli, A, Sanfilippo, E

مصطلحات موضوعية: Settore SECS-P/04 - STORIA DEL PENSIERO ECONOMICO

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000261647000001; volume:40; issue:4; firstpage:569; lastpage:594; journal:HISTORY OF POLITICAL ECONOMY; http://hdl.handle.net/2108/14951Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-58149091117

الإتاحة: https://doi.org/10.1215/00182702-2008-027Test
http://hdl.handle.net/2108/14951Test

View record in BASE

7

Liberare Gramsci: la proposta di scambio dell’autunno 1927

المؤلفون: Naldi, N.

مصطلحات موضوعية: Antonio Gramsci, trattativa, liberazione, scambio prigionieri, liberazione, scambio prigionieri, trattativa, Antonio Gramsci

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3686::bb5cf75ad41f3f49e4a4b1db140f5d60Test
http://hdl.handle.net/11573/1571351Test

8

دورية أكاديمية

Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

المؤلفون: Musolino, A, Cavanna, L, Boggiani, D, Zamagni, C, Frassoldati, A, Caldara, A, Rocca, A, Gori, S, Piacentini, F, Berardi, R, Brandes, AA, Foglietta, J, Villa, F, Pellegrino, B, Todeschini, R, Tognetto, M, Naldi, N, Bortesi, B, Boni, L, Montemurro, F, Ardizzoni, A

المساهمون: Musolino, A, Cavanna, L, Boggiani, D, Zamagni, C, Frassoldati, A, Caldara, A, Rocca, A, Gori, S, Piacentini, F, Berardi, R, Brandes, Aa, Foglietta, J, Villa, F, Pellegrino, B, Todeschini, R, Tognetto, M, Naldi, N, Bortesi, B, Boni, L, Montemurro, F, Ardizzoni, A

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000478677000278; volume:79; issue:4; firstpage:P1-14-05; lastpage:P1-14-05; journal:CANCER RESEARCH; http://hdl.handle.net/11381/2875413Test

الإتاحة: https://doi.org/10.1158/1538-7445.SABCS18-P1-14-05Test
http://hdl.handle.net/11381/2875413Test

View record in BASE

9

دورية أكاديمية

Mechanism of action and clinical efficacy of CDK4/6 inhibitors in BRCA-mutated, estrogen receptor-positive breast cancers: Case report and literature review

المؤلفون: Militello A. M., Zielli T., Boggiani D., Michiara M., Naldi N., Bortesi B., Zanelli P., Uliana V., Giuliotti S., Musolino A.

المساهمون: Militello, A. M., Zielli, T., Boggiani, D., Michiara, M., Naldi, N., Bortesi, B., Zanelli, P., Uliana, V., Giuliotti, S., Musolino, A.

مصطلحات موضوعية: BRCA, Breast cancer, CDK4/6 inhibitor, Cyclin D1, Endocrine therapy, Estrogen receptor, Homologous recombination

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000480527600001; volume:9; issue:AUG; firstpage:759; journal:FRONTIERS IN ONCOLOGY; http://hdl.handle.net/11381/2875168Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85071694056

الإتاحة: https://doi.org/10.3389/fonc.2019.00759Test
http://hdl.handle.net/11381/2875168Test

View record in BASE

10

دورية أكاديمية

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

المؤلفون: Tiseo, M, Bordi, P, Bortesi, B, Boni, L, Boni, C, Baldini, E, Grossi, F, Recchia, F, Zanelli, F, Fontanini, G, Naldi, N, Campanini, N, Azzoni, C, Bordi, C, Ardizzoni, A

المصدر: British Journal of Cancer ; volume 108, issue 8, page 1695-1703 ; ISSN 0007-0920 1532-1827

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1038/bjc.2013.127Test
http://www.nature.com/articles/bjc2013127.pdfTest
http://www.nature.com/articles/bjc2013127Test

View record in BASE

تنقيح النتائج